创胜集团-B宣布达成战略合作与非排他性许可协议推动集成连续生物制造技术发展并扩大全球可负担生物药可及性_老虎社区_美港股上老虎

创胜集团-B宣布达成战略合作与非排他性许可协议推动集成连续生物制造技术发展并扩大全球可负担生物药可及性

美股速递2025-12-29

创胜集团-B宣布已达成一项战略合作及非排他性许可协议，旨在推进集成连续生物制造技术的应用，并拓展全球范围内对可负担生物药物的可及性。该合作将促进先进制造工艺的部署，有望提升生物药的生产效率并降低成本，从而惠及更广泛的全球患者群体。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1105542339?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-29 08:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105542339","market":"us","top_or_hot":-1,"title":"创胜集团-B宣布达成战略合作与非排他性许可协议 推动集成连续生物制造技术发展并扩大全球可负担生物药可及性","media":"美股速递","content":"<p>创胜集团-B宣布已达成一项战略合作及非排他性许可协议，旨在推进集成连续生物制造技术的应用，并拓展全球范围内对可负担生物药物的可及性。该合作将促进先进制造工艺的部署，有望提升生物药的生产效率并降低成本，从而惠及更广泛的全球患者群体。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>创胜集团-B宣布达成战略合作与非排他性许可协议 推动集成连续生物制造技术发展并扩大全球可负担生物药可及性</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n创胜集团-B宣布达成战略合作与非排他性许可协议 推动集成连续生物制造技术发展并扩大全球可负担生物药可及性\n</h2>\n\n<h4 class=\"meta\">\n\n2025-12-29 08:08 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>创胜集团-B宣布已达成一项战略合作及非排他性许可协议，旨在推进集成连续生物制造技术的应用，并拓展全球范围内对可负担生物药物的可及性。该合作将促进先进制造工艺的部署，有望提升生物药的生产效率并降低成本，从而惠及更广泛的全球患者群体。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1105542339","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105542339","pubTimestamp":1766966930,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"创胜集团-B宣布已达成一项战略合作及非排他性许可协议，旨在推进集成连续生物制造技术的应用，并拓展全球范围内对可负担生物药物的可及性。该合作将促进先进制造工艺的部署，有望提升生物药的生产效率并降低成本，从而惠及更广泛的全球患者群体。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","06628":"创胜集团-B"},"translate_title":"Chuangsheng Group-B announces strategic cooperation and non-exclusive licensing agreement to promote the development of integrated continuous biomanufacturing technology and expand global access to affordable biologics","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06628":1},"content_text":"创胜集团-B宣布已达成一项战略合作及非排他性许可协议，旨在推进集成连续生物制造技术的应用，并拓展全球范围内对可负担生物药物的可及性。该合作将促进先进制造工艺的部署，有望提升生物药的生产效率并降低成本，从而惠及更广泛的全球患者群体。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}